Meet Roni Nitecki Wilke, M.D.
Roni Nitecki Wilke, M.D., M.P.H.
Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
About Dr. Roni Wilke
Dr. Wilke is an assistant professor in the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. She completed her medical education at Dartmouth Medical School, residency training at Brigham and Women’s Hospital and Massachusetts General Hospital, and fellowship training at MD Anderson.
The ability to be the primary physician and surgeon for patients with gynecologic cancers and pre-invasive disease by administering systemic therapy and offering specialized surgery via laparoscopic, robotic, and open approaches is her calling. She is committed to providing the highest quality evidence-based, multidisciplinary, and honest care to her patients. Her research interests include prevention of hereditary cancer, fertility sparing approaches in young patients with gynecologic cancer, surgical outcomes, and financial barriers to cancer care. She has authored and co-authored original research in numerous peer-reviewed journals.
Present Title & Affiliation
Primary Appointment
Assistant Professor, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2020 | University of Texas School of Public Health, Houston, Texas, US, Epidemiology, MPH |
| 2015 | Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, US, MD |
| 2011 | Dartmouth College, Hanover, New Hampshire, US, Neuroscience, BA |
Postgraduate Training
| 2019-2023 | Clinical Fellowship, Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas |
| 2015-2019 | Clinical Residency, Obstetrics and Gynecology, Brigham and Women's Hospital and Massachusetts General Hospital, Boston, Massachusetts |
Licenses & Certifications
| 2026 | Gynecologic Oncology |
| 2023 | American Board of Obstetrics and Gynecology |
Experience & Service
Extramural Institutional Committee Activities
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2023 - Present
Honors & Awards
| 2020 | Merit Award Recipient, The American Society of Clinical Oncology |
| 2017 | New England Association for Gynecologic Oncology Award for Best Research Presentation |
| 2017 | Excellent Resident Teacher, Brigham and Women’s Hospital and Massachusetts General Hospital |
| 2015 | The Saul Blatman Award for Excellence in Maternal and Child Health, Geisel School of Medicine at Dartmouth |
| 2015 | Alpha Omega Alpha, Geisel School of Medicine at Dartmouth |
| 2015 | Dartmouth-Mosenthal Surgical Society, Geisel School of Medicine at Dartmouth |
| 2015 | The Dean’s Medal for Best Academic Record in the Graduating Class, Gesiel School of Medicine at Dartmouth |
| 2011 | Dean’s Plate Award for Academic Honors and Service to the Community, Dartmouth College |
| 2011 | Neuroscience Department Nomination for the Jonathan B. Rintel’s Prize for the best Honors Thesis, Dartmouth College |
| 2011 | Marcus Heiman-Martin Rosenthal ’56 Achievement Award for Achievement in the Arts: Dance, Dartmouth College |
| 2010 | David C. Hodgson Endowment for Undergraduate Research Award, Dartmouth College |
Grant & Contract Support
| Date: | 2026 - Present |
| Title: | Development of a Multilevel Intervention to Support Pregnancy Decision-Making Among Adolescent and Young Adult Cancer Survivors |
| Funding Source: | Internal Research Grant - Cancer Survivorship Research Seed Money Grant |
| Role: | PI |
| Date: | 2025 - Present |
| Title: | Tirzepatide with Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer in Overweight and Obese Women |
| Funding Source: | NCI |
| Role: | Co-PI |
| ID: | MDA24-19-01 |
| Date: | 2022 - Present |
| Title: | TUBA-WISP II Study |
| Funding Source: | Minnesota Ovarian Cancer Alliance |
| Role: | Co-PI |
| Date: | 2022 - Present |
| Title: | Understanding and Intercepting Ovarian Carcinogenesis |
| Funding Source: | Break Through Cancer |
| Role: | Co-PI |
| Title: | Leveraging transposable elements towards immunoprevention of ovarian cancer |
| Funding Source: | FWC |
| Role: | Co-I |
| ID: | 5561 |
Selected Publications
Peer-Reviewed Articles
- Eyada, M, Michael, V, Patel, S, How, JA, Wilke, RN, Jazaeri, AA, Fleming, N, Soliman, PT, Sood, AK, Westin, SN, Sims, TT. Oral cyclophosphamide combined with bevacizumab in recurrent heavily pre-treated ovarian cancer. International Journal of Gynecological Cancer 36(8), 2026. e-Pub 2026. PMID: 42259216.
- Viveros-Carreño, D, Garcia, NA, Mora-Soto, N, Beshar, I, Angeles, MA, Rodriguez, J, Krause, KJ, Iniesta-Donate, M, Wilke, RN, Melamed, A, Rauh-Hain, JA, Pareja, R. Frequency of lymph node involvement in clinically early-stage low-grade serous ovarian cancer. International Journal of Gynecological Cancer 36(8), 2026. e-Pub 2026. PMID: 42263579.
- Levin, G, Garcia, NA, Beshar, I, Ribeiro, R, Wilke, RN, Melamed, A, Iniesta-Donate, M, Meyer, R, Rauh-Hain, JA. Robotic vs laparoscopic interval cytoreductive surgery in stage III ovarian cancer. International Journal of Gynecological Cancer 36(7), 2026. e-Pub 2026. PMID: 42302709.
- Bou Zerdan, M, Kfoury, B, Aoun, E, Hmaidan, SD, Wilke, RN, How, JA, Woodard, TL, Soliman, PT, McKenzie, LJ. Pregnancy Outcomes After in Utero Exposure to Immune Checkpoint Inhibitors. Current Oncology 33(6), 2026. e-Pub 2026. PMID: 42346218.
- Lopez, S, Rivera, LD, Kirby, M, Karimaghaie, T, Epstein, ES, Wilke, RN, Rauh-Hain, JA, Sharaf, RN, Frey, MK. Clinician-facilitated cascade genetic testing among first-, second-, and third-degree relatives. Journal of Clinical Oncology 44:e13584–e13584, 2026. e-Pub 2026.
- Epstein ES, Primiano M, Ozarowski AL, Karimaghaie T, Kirby M, Lopez S, Rauh-Hain JA, Wilke RN, Moss HA, Brewer J, Levi SR, LaRosa T, Kalyan A, Llenas A, Marchal S, Song LB, Ahsan MD, Sharaf RN, Frey MK. ACT-ON: Assisted cascade testing via outreach and navigation - Real-world experience with clinician-facilitated cascade testing. Gynecol Oncol 207(April 2026):38-46, 2026. e-Pub 2026. PMID: 42000374.
- Agusti N, Viveros-Carreno D, Wu CF, Iniesta MD, Kanbergs A, Wilke RN, Bercow A, Barajas K, Pareja R, Melamed A, Rauh-Hain JA. Survival Outcomes After Inadvertent Surgery in Low-Risk Early-Stage Cervical Cancer. Am J Obstet Gynecol 234(6):1639-1649, 2026. e-Pub 2026. PMID: 41707895.
- Wilke, RN, Agusti, N, Garcia, NA, Wu, C, Iniesta-Donate, M, Manning, W, Viveros-Carreño, D, Kurian, A, Rauh-Hain, JA, Melamed, A. Association between germline BRCA1 pathogenic variants and uterine serous carcinoma among women with breast cancer. American journal of obstetrics and gynecology 234(2):e37-e41, 2026. e-Pub 2026. PMID: 41109496.
- Aoun E, Lawson B, Awujo C, Nebgen D, Soletsky BR, Chisholm GB, Lu KH, Wilke RN. Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgery. Int J Gynecol Cancer 36(2):101870, 2026. e-Pub 2026. PMID: 39496390.
- Gootzen TA, Steenbeek MP, van Gelder MMHJ, van Bommel MHD, Timmer-Bonte AJNH, Kets CM, Nitecki-Wilke R, Swisher EM, Norquist BM, Lu KH, Hermens RPMG, de Hullu JA. Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study. Am J Obstet Gynecol 233(6):638.e1-638.e13, 2025. e-Pub 2025. PMID: 40532962.
- Abel MK, Kanbergs A, Wu CF, Perkins G, Agusti N, Viveros-Carreno D, Wilke RN, Barajas K, Rauh-Hain JA, Melamed A. Racial Differences in Live-Birth Outcomes After a Breast Cancer Diagnosis. O G Open 2(6):e133, 2025. e-Pub 2025. PMID: 41235395.
- Kanbergs A, Agusti N, Perkins G, Wu CF, Viveros-Carreno D, Iniesta MD, Barajas K, Melamed A, Rauh-Hain JA, Wilke RN. Trends and clinical predictors in ovarian preservation in patients with low-risk endometrial cancer. Am J Obstet Gynecol 234(3):650-667, 2025. e-Pub 2025. PMID: 41223960.
- Iniesta-Donate, M, Munsell, M, Zorrilla-Vaca, A, Ramirez, PT, Garcia-Lopez, J, Basabe, M, Wilke, RN, Taylor, JS, Cain, K, Lasala, J, Mena, GE, Meyer, LA. Impact of an enhanced recovery after surgery program on outcomes in elderly patients undergoing open gynecologic surgery. International Journal of Gynecological Cancer 35(11), 2025. e-Pub 2025. PMID: 41061500.
- Wilke, RN, Liu, J, Westin, SN, Fellman, B, Sims, TT, Pham, MM, Rangel, KM, Sey, E, Rauh-Hain, JA, Lu, KH, Sood, AK, Fleming, N. The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapy. International Journal of Gynecological Cancer 35(11), 2025. e-Pub 2025. PMID: 39414313.
- Wilke RN, Pennington KP, Gootzen TA, Steenbeek MP, de Hullu JA, Long KC, Blank SV, Swisher EM, Lu KH, Norquist B. Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution. Am J Obstet Gynecol 234(4):1003-1006, 2025. e-Pub 2025. PMID: 41183726.
- Reddy RA, Wilke RN, Soliman PT, Westin SN, How JA. Fertility-Sparing Practices in Uterine Malignancies: A Literature Review. Journal of Gynecologic Surgery, 2025.
- Knisely A, Dai Y, Barlow GL, Lee S, Lawson B, Clark H, Fellman B, Yuan Y, Lu W, Lubo Julio IC, Lazcano RN, Chelvanambi M, Melendez B, Singh B, Singh B, Wani K, Chen J, Yeh CC, Gao J, Barnes S, Shi O, Khan KB, Serrano AG, Gomez-Bolanos LI, Scalise CB, Cheung SK, Dutta P, Velichko S, ElNaggar AC, Liu MC, Wilke RN, How J, Ramondetta LM, Boruta DM, Richardson G, Shafer A, Westin SN, Sims T, Sood AK, Ramirez PT, Lazar AJ, Soliman PT, Lu K, Haymaker CL, Solis Soto LM, Wargo JA, Grisham R, Wucherpfennig KW, Wang L, Jazaeri AA. Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities. Clin Cancer Res 31(19):4122-4135, 2025. e-Pub 2025. PMID: 40748258.
- Kanbergs A, Perkins G, Wu CF, Melamed A, Agusti N, Viveros-Carreno D, Barajas K, Bercow AS, Rauh-Hain JA, Nitecki Wilke R. Effect of Geospatial and Sociodemographic Factors on Live Birth After Fertility-Sparing Treatment for Breast and Gynecologic Cancers. O G Open 2(5):e123, 2025. e-Pub 2025. PMID: 41142663.
- Abel, MK, Mazina, V, Bregar, AJ, Gockley, AA, Del Carmen, MG, Eisenhauer, EL, Wilke, RN, Rauh-Hain, JA, Dottino, JA, Melamed, A. Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer. JAMA Network Open 8(7), 2025. e-Pub 2025. PMID: 40711787.
- Wilke, RN, Wu, C, Kanbergs, A, Bercow, AS, Garcia, NA, Viveros-Carreño, D, Zamorano, AS, Rauh-Hain, JA, Melamed, A. Disparities in facility-level adoption of minimally invasive interval debulking surgery for advanced ovarian cancer. Gynecologic oncology 197:11-18, 2025. e-Pub 2025. PMID: 40250029.
- Garcia, NA, Viveros-Carreño, D, Wu, C, Wilke, RN, Kanbergs, A, Barajas, K, Zamorano, AS, Pareja, R, Melamed, A, Rauh-Hain, JA. Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer. JAMA Oncology 11(5):511-518, 2025. e-Pub 2025. PMID: 40079948.
- Kanbergs, A, Clapp, MA, Wu, C, Melamed, A, Garcia, NA, Viveros-Carreño, D, Zamorano, AS, Virili, F, Rauh-Hain, JA, Wilke, RN. Cancer diagnosis during pregnancy is associated with severe maternal and neonatal morbidity. American journal of obstetrics and gynecology 232(5):466.e1-466.e29, 2025. e-Pub 2025. PMID: 39447820.
- Kanbergs, A, Melamed, A, Viveros-Carreño, D, Wu, C, Wilke, RN, Zamorano, AS, Paladuga, K, Havrilesky, LJ, Rauh-Hain, JA, Garcia, NA. Surgical Deescalation Within Gynecologic Oncology. JAMA Network Open 8(1):e2453604, 2025. e-Pub 2025. PMID: 39775807.
Review Articles
- Viveros-Carreño, D, Beshar, I, Garcia, NA, Murthy, A, Mora-Soto, N, Iniesta-Donate, M, Barajas, K, Melamed, A, Rauh-Hain, JA, Wilke, RN. Contemporary risk assessment and risk-reducing strategies for tubo-ovarian cancer in women with BRCA pathogenic variants. International Journal of Gynecological Cancer 36(6), 2026. e-Pub 2026. PMID: 42056783.
- Viveros-Carreño D, Agustí N, Mora-Soto N, Wilke RN, Pareja R. De-escalation in definitive surgical management for cervical cancer. Int J Gynecol Cancer 36(3), 2026. e-Pub 2026. PMID: 41775568.
- Beshar I, Agusti N, Barajas K, Krause K, Nitecki Wilke R, Rauh-Hain JA. Barriers and interventions to improve the uptake of cancer risk management strategies in hereditary cancer syndromes: a narrative review. Int J Gynecol Cancer 36(1):102825, 2026. e-Pub 2026. PMID: 41494213.
Editorials
- Wilke, RN, Lu, KH. Serous Tubal Intraepithelial Carcinoma. Obstetrics and gynecology 146(3):299-301, 2025.
Book Chapters
- Nitecki R, Cobb LP, Rauh-Hain JA, Jazaeri AA. Ovarian Cancer. In: The MD Anderson Manual of Medical Oncology. 4th, 2022.
- Nitecki R, Rauh-Hain JA. Uterine Leiomyosarcoma. In: Petrozza JC, Ed. CRC Press, 2020.
Patient Reviews
CV information above last modified September 03, 2026